Voluntary ex ante transparency notice
Directive 2014/24/EU
Section I: Contracting
entity
I.1) Name and addresses
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw
Cardiff
CF15 7QZ
UK
Telephone: +44 1443848585
E-mail: rhodri.poacher@wales.nhs.uk
NUTS: UK
Internet address(es)
Main address: http://nwssp.nhs.wales/ourservices/procurement-services/
Address of the buyer profile: https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
PICCOS TRIAL
Reference number: CAV-STA (22-23) 212
II.1.2) Main CPV code
79314000
II.1.3) Type of contract
Services
II.1.4) Short description
This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
1 974 920.41
GBP
II.2) Description
II.2.2) Additional CPV code(s)
79314000
II.2.3) Place of performance
NUTS code:
UKL22
Main site or place of performance:
University Hospital of Wales.
II.2.4) Description of the procurement
Bowel, ovarian and stomach cancer often spreads to the lining of the abdominal cavity. This trial aims to determine if a new way of delivering chemotherapy as a spray, directly into the peritoneal cavity, might improve survival in patients with peritoneal metastases, compared to conventional intravenous chemotherapy. Critically, we will also assess the impact of treatment on patient quality of life.
Up to 13%, 50% and 14% of patients with bowel, ovarian and stomach cancer respectively, present with
peritoneal metastases. When this form of spread occurs, patients are normally told their disease is
incurable. As well as a relatively rapid decline, peritoneal metastases can cause a series of unpleasant
symptoms due to new tumour growth. Peritoneal metastases are difficult to treat with conventional anticancer drugs and there is an urgent need to develop new treatment strategies. A new strategy showing
potential is Pressurised IntraPeritoneal Aerosol Chemotherapy (PIPAC). PIPAC delivers anti-cancer
drugs into the peritoneal cavity as an aerosol during keyhole surgery. PIPAC has been shown to deliver
higher doses of chemotherapy directly to tumour sites compared to conventional treatment, with fewer
side-effects due to less chemotherapy circulating in the blood. PIPAC has been shown to be both safe and feasible in a series of clinical trials. The question that now remains is whether PIPAC is efficacious
or not.
PIPAC has excited much interest in patient groups. CAV will disseminate study results through social
media, relevant charitable organisations, presentation at academic conferences, peer-reviewed journals
as well as through the trial web page hosted at the Centre for Trials Research. Information leaflets,
public presentations and media coverage are integral elements of our public engagement plans. The
results will strongly influence a future NICE review of PIPAC in the UK.
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation:
This contract will be awarded to the Cardiff University, who have senior personnel with a large amount of experience in this area of research who are leading on this research project.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
Section V: Award of contract/concession
Contract No: CAV-STA (22-23) 212
V.2 Award of contract/concession
V.2.1) Date of conclusion of the contract/concession
11/05/2023
V.2.2) Information about tenders
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
CARDIFF UNIVERSITY
CARDIFF UNIVERSITY, 30 36 NEWPORT ROAD
CARDIFF
CF240DE
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the concession and main financing terms (excluding VAT)
Total value of the concession/lot:
1 974 920.41
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This VEAT will be in place for 10 calendar days from 11th May 2023 until 22nd May 2023.
NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at http://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=131480.
(WA Ref:131480)
VI.4) Procedures for review
VI.4.1) Review body
High Court
Royal Courts of Justice, The Strand
London
WC2A 2LL
UK
Telephone: +44 2079477501
VI.5) Date of dispatch of this notice
11/05/2023